Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-03-11

Clinical Trial Update: Efficacy and Safety of a Purified Standardised Wasp Venom Preparation [Phase 3]

View source ↗

Summary

A completed Phase 3 trial evaluating the efficacy and safety of a purified standardised wasp venom preparation for insect venom allergy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Purified standardised wasp venom preparation (wasp venom immunotherapy extract)

Snippet

Sponsor: Allergopharma GmbH & Co. KG | Conditions: Allergy | Phase 3 | Status: COMPLETED